Available datapackage for study 'A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)'

Name: Available datapackage for study 'A Phase III Randomised, Double-blind Trial to Evaluate Efficacy and Safety of Once Daily Empagliflozin 10 mg Compared to Placebo, in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)'
Creator: Vivli
Published: 2026-01-08 06:18:57
License: 暂无描述

DataCite Commons2026-01-08 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/dataPackages/PR00008832.2

下载链接

链接失效反馈

官方服务：

资源简介：

The aim of the study is to investigate the safety and efficacy of empagliflozin versus placebo on top of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.

提供机构：

Vivli

创建时间：

2026-01-08